Chemists have succeeded in synthesizing a normal compound that shows promise to be a painkiller--and won't result in the side effects that bedevil analgesics presently utilized to deal with acute and Serious conditions. The interactions among the opioid peptides and classical receptors result in a cascade of protein signaling https://www.proleviate.com/post/the-new-pain-killer-conolidine